Guardant Health, Inc. (GH) — 8-K Filings

8-K Filings (19)

• Guardant Health Announces Executive Officer Changes — Apr 27, 2026 Risk: medium
  On April 27, 2026, Guardant Health, Inc. filed an 8-K report detailing a change in its executive officer structure. The filing specifically addresses Item 5.02,
• 8-K Filing — Nov 7, 2025
• Guardant Health Files 8-K — Sep 24, 2025 Risk: low
  Guardant Health, Inc. filed an 8-K on September 24, 2025, to report information under Regulation FD. The filing does not contain specific financial transactions
• Guardant Health Announces Board and Executive Changes — Sep 15, 2025 Risk: medium
  Guardant Health, Inc. announced on September 12, 2025, changes in its board of directors and executive compensation. The filing details the departure of certain
• Guardant Health Reports on Shareholder Vote — Jun 20, 2025 Risk: low
  Guardant Health, Inc. filed an 8-K on June 20, 2025, reporting on matters submitted to a vote of its security holders on June 18, 2025. The filing details the c
• Guardant Health Files 8-K for Material Agreement — Apr 9, 2025 Risk: medium
  Guardant Health, Inc. entered into a material definitive agreement on April 3, 2025. This filing also indicates the creation of a direct financial obligation or
• Guardant Health Files 8-K on Agreements and Equity Sales — Feb 14, 2025 Risk: medium
  Guardant Health, Inc. filed an 8-K on February 14, 2025, reporting on several key events. These include entering into a material definitive agreement, creating
• Guardant Health Files 8-K: Material Agreement & Equity Sales — Feb 7, 2025 Risk: medium
  On February 6, 2025, Guardant Health, Inc. entered into a material definitive agreement. The company also reported on unregistered sales of equity securities an
• Guardant Health Files 8-K on Financials — Jan 13, 2025 Risk: low
  Guardant Health, Inc. filed an 8-K on January 13, 2025, reporting on its results of operations and financial condition. The filing also included Regulation FD d
• Guardant Health Appoints New Director, Updates Executive Compensation — Oct 24, 2024 Risk: low
  Guardant Health, Inc. announced on October 21, 2024, changes in its officer and director positions. The company elected a new director, Dr. Amirali Z. Hirji, an
• Guardant Health Enters Material Definitive Agreement — Aug 23, 2024 Risk: medium
  Guardant Health, Inc. announced on August 23, 2024, that it has entered into a material definitive agreement. The filing does not disclose specific details of t
• Guardant Health Files 8-K Regulatory Update — Jul 29, 2024 Risk: low
  Guardant Health, Inc. filed an 8-K on July 29, 2024, to report other events and financial statements. The filing does not contain specific details about new agr
• Guardant Health Announces Board and Executive Compensation Changes — Jul 18, 2024 Risk: low
  Guardant Health, Inc. announced on July 17, 2024, changes in its board of directors and executive compensation arrangements. Specifically, the company reported
• Guardant Health Reports on Shareholder Vote Matters — Jun 14, 2024 Risk: low
  Guardant Health, Inc. filed an 8-K on June 14, 2024, reporting on matters submitted to a vote of security holders on June 12, 2024. The filing details the compa
• Guardant Health Appoints New CEO, Adds Directors — May 31, 2024 Risk: medium
  Guardant Health, Inc. announced on May 24, 2024, a change in its board of directors. Specifically, Dr. Amirali Talasaz has been appointed as the new Chief Execu
• Verily to Acquire Guardant Health for $5.1B — May 24, 2024 Risk: medium
  Guardant Health, Inc. announced on May 23, 2024, that it has entered into a definitive agreement to be acquired by Verily Life Sciences, a subsidiary of Alphabe
• Guardant Health Announces Executive Changes and Board Appointments — Mar 22, 2024 Risk: medium
  Guardant Health, Inc. announced on March 18, 2024, the departure of its Chief Medical Officer, Dr. Amirali Talasaz, effective March 15, 2024. The company also r
• Guardant Health Amends Executive Compensation Arrangements — Feb 1, 2024
  Guardant Health, Inc. filed an 8-K on February 1, 2024, reporting an event on January 26, 2024, related to changes in its executive compensation arrangements. T
• Guardant Health 8-K Signals Upcoming Financial Disclosure — Jan 8, 2024
  Guardant Health, Inc. filed an 8-K on January 8, 2024, indicating that it will be disclosing information related to its 'Results of Operations and Financial Con

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX